These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19653786)

  • 21. Neuroendocrine effects of d-fenfluramine and bromocriptine following repeated smoked cocaine in humans.
    Haney M; Ward AS; Gerra G; Foltin RW
    Drug Alcohol Depend; 2001 Sep; 64(1):63-73. PubMed ID: 11470342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolonged deficits in presynaptic serotonin function following withdrawal from chronic cocaine exposure as revealed by 5-HTP-induced head-twitch response in mice.
    Darmani NA; Shaddy J; Elder EL
    J Neural Transm (Vienna); 1997; 104(11-12):1229-47. PubMed ID: 9503268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mirtazapine attenuates anxiety- and depression-like behaviors in rats during cocaine withdrawal.
    Barbosa Méndez S; Salazar-Juárez A
    J Psychopharmacol; 2019 May; 33(5):589-605. PubMed ID: 31012359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of methadone or buprenorphine maintenance on the subjective and reinforcing effects of intravenous cocaine in humans.
    Foltin RW; Fischman MW
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1153-64. PubMed ID: 8819498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Desipramine in the treatment of hypersomnolence following abrupt cessation of cocaine use.
    Baxter LR
    Am J Psychiatry; 1983 Nov; 140(11):1525-6. PubMed ID: 6625009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased non-rapid eye movement sleep by cocaine withdrawal: possible involvement of A2A receptors.
    Yang SL; Han JY; Kim YB; Nam SY; Song S; Hong JT; Oh KW
    Arch Pharm Res; 2011 Feb; 34(2):281-7. PubMed ID: 21380812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperprolactinemia during cocaine withdrawal.
    Mendelson J; Teoh S; Lange U; Mello N; Weiss R; Skupny A
    NIDA Res Monogr; 1988; 81():67-73. PubMed ID: 3136392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Smoked cocaine self-administration in females and voucher incentives for abstinence.
    Evans SM; Levin FR; Fischman MW; Foltin RW
    J Subst Abuse; 1998; 10(2):143-62. PubMed ID: 9854700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous or intermittent cocaine administration: effects of amantadine treatment during withdrawal.
    King GR; Joyner C; Ellinwood EH
    Pharmacol Biochem Behav; 1994 Mar; 47(3):451-7. PubMed ID: 8208762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationships between individual sensitivity to CS- and cocaine-induced reinstatement in the rat.
    Deroche-Gamonet V; Martinez A; Le Moal M; Piazza PV
    Psychopharmacology (Berl); 2003 Jul; 168(1-2):201-207. PubMed ID: 12589518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and safety of escalating single and repeat oral doses of GW420867X, a novel non-nucleoside reverse transcriptase inhibitor.
    Moore KH; Cass LM; Dallow N; Hardman TC; Jones A; Boyce M; Prince WT
    Eur J Clin Pharmacol; 2001; 56(11):805-11. PubMed ID: 11294370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute abstinence effects following smoked cocaine administration in humans.
    Dudish-Poulsen S; Hatsukami DK
    Exp Clin Psychopharmacol; 2000 Nov; 8(4):472-82. PubMed ID: 11127419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations in BDNF and trkB mRNAs following acute or sensitizing cocaine treatments and withdrawal.
    Filip M; Faron-Górecka A; Kuśmider M; Gołda A; Frankowska M; Dziedzicka-Wasylewska M
    Brain Res; 2006 Feb; 1071(1):218-25. PubMed ID: 16423334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response to cocaine, alone and in combination with methylphenidate, in cocaine abusers with ADHD.
    Collins SL; Levin FR; Foltin RW; Kleber HD; Evans SM
    Drug Alcohol Depend; 2006 Apr; 82(2):158-67. PubMed ID: 16213109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic cocaine exposure potentiates prolactin and head shake responses to 5-HT2 receptor stimulation in rats.
    Baumann MH; Rothman RB
    Neuropharmacology; 1996 Mar; 35(3):295-301. PubMed ID: 8783204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cocaine use and withdrawal: the effect on sleep and mood.
    Watson R; Bakos L; Compton P; Gawin F
    Am J Drug Alcohol Abuse; 1992; 18(1):21-8. PubMed ID: 1562006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypothalamic-pituitary function during alcohol exposure and withdrawal and cocaine exposure.
    Wilkins JN; Gorelick DA; Nademanee K; Taylor A; Herzberg DS
    Recent Dev Alcohol; 1992; 10():57-71. PubMed ID: 1317048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotonergic responsiveness in human cocaine users.
    Ghitza UE; Rothman RB; Gorelick DA; Henningfield JE; Baumann MH
    Drug Alcohol Depend; 2007 Jan; 86(2-3):207-13. PubMed ID: 16930852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anxiety-like responses in adolescent rats following a 10-11-day withdrawal period from repeated cocaine administration.
    Santucci AC; Rosario A
    Brain Res Bull; 2010 Mar; 81(4-5):441-4. PubMed ID: 19963046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacodynamic effects and relationships to plasma and oral fluid pharmacokinetics after intravenous cocaine administration.
    Ellefsen KN; Concheiro M; Pirard S; Gorelick DA; Huestis MA
    Drug Alcohol Depend; 2016 Jun; 163():116-25. PubMed ID: 27114201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.